Cancer-Related Fatigue in Patients With and Survivors of Hodgkin Lymphoma: The Impact on Treatment Outcome and Social Reintegration

被引：81

作者：

Behringer, Karolin ^{[1
]}

Goergen, Helen ^{[1
]}

Mueller, Horst ^{[1
]}

Thielen, Indra ^{[1
]}

Brillant, Corinne ^{[1
]}

Kreissl, Stefanie ^{[1
]}

Halbsguth, Teresa Veronika ^{[3
]}

Meissner, Julia ^{[4
]}

Greil, Richard ^{[6
]}

Moosmann, Peter ^{[7
,8
]}

Shonukan, Oluwatoyin ^{[9
]}

Rueffer, Jens Ulrich ^{[2
]}

Flechtner, Hans-Henning ^{[5
]}

Fuchs, Michael ^{[1
]}

Diehl, Volker ^{[1
]}

Engert, Andreas ^{[1
]}

Borchmann, Peter ^{[1
]}

机构：

[1] Univ Hosp Cologne, Cologne, Germany

[2] German Fatigue Soc, Cologne, Germany

[3] Univ Hosp Frankfurt, Frankfurt, Germany

[4] Heidelberg Univ, Heidelberg, Germany

[5] Otto von Guericke Univ, Magdeburg, Germany

[6] Paracelsus Med Univ, Salzburg, Austria

[7] Cantonal Hosp Aarau AG, Aarau, Switzerland

[8] Swiss Grp Clin Canc Res, Bern, Switzerland

[9] Boston Univ, Sch Publ Hlth, Boston, MA USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 36期

关键词：

QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; COGNITIVE-BEHAVIOR THERAPY; NON-INFERIORITY TRIAL; DISEASE SURVIVORS; CLINICAL-TRIALS; BREAST-CANCER; OPEN-LABEL; EXERCISE; ONCOLOGY;

D O I：

10.1200/JCO.2016.67.7450

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Purpose Cancer-related fatigue occurs frequently in patients with Hodgkin lymphoma (HL) and has a major impact on their quality of life. We hypothesized that severe fatigue (sFA) might have an impact on patients' treatment outcome and social reintegration. Methods Of 5,306 patients enrolled in the German Hodgkin Study Group's fifth generation of clinical trials in HL (HD13, HD14, and HD15; nonqualified and older [>60 years] patients excluded), 4,529 provided data on health-related quality of life. We describe sFA (defined as a score >= 50 on the 0 to 100 scale from the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30) before and up to 9 years after therapy and analyze its impact on treatment outcome and social reintegration. Results The proportion of patients reporting sFA was 37% at baseline and ranged from 20% to 24% during follow-up. Baseline sFA was associated with significantly impaired progression-free survival and a trend to impaired overall survival, which can be overcome in patients receiving highly effective HL therapies as applied in our fifth-generation trials. Our analysis revealed a significant negative association of sFA and employment in survivors: 5 years after therapy, 51% and 63% of female and male survivors, respectively, with sFA were working or in professional education, compared with 78% and 90% without sFA, respectively (P < .001 adjusted for age, sex, stage, baseline employment status, and treatment outcome). sFA was also associated with financial problems and the number of visits to a general practitioner and medical specialists. Conclusion sFA is an important factor preventing survivors from social reintegration during follow-up. This observation underscores the need to address fatigue as a significant diagnosis when treating patients with and survivors of cancer. (C) 2016 by American Society of Clinical Oncology

引用

页码：4329 / +

页数：17

共 31 条

[1] THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].

AARONSON, NK ;

AHMEDZAI, S ;

BERGMAN, B ;

BULLINGER, M ;

CULL, A ;

DUEZ, NJ ;

FILIBERTI, A ;

FLECHTNER, H ;

FLEISHMAN, SB ;

DEHAES, JCJM ;

KAASA, S ;

KLEE, M ;

OSOBA, D ;

RAZAVI, D ;

ROFE, PB ;

SCHRAUB, S ;

SNEEUW, K ;

SULLIVAN, M ;

TAKEDA, F .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376

[2] Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial [J].

Behringer, Karolin ;

Goergen, Helen ;

Hitz, Felicitas ;

Zijlstra, Josee M. ;

Greil, Richard ;

Markova, Jana ;

Sasse, Stephanie ;

Fuchs, Michael ;

Topp, Max S. ;

Soekler, Martin ;

Mathas, Stephan ;

Meissner, Julia ;

Wilhelm, Martin ;

Koch, Peter ;

Lindemann, Hans-Walter ;

Schalk, Enrico ;

Semrau, Robert ;

Kriz, Jan ;

Vieler, Tom ;

Bentz, Martin ;

Lange, Elisabeth ;

Mahlberg, Rolf ;

Hassler, Andre ;

Vogelhuber, Martin ;

Hahn, Dennis ;

Mezger, Joerg ;

Krause, Stefan W. ;

Skoetz, Nicole ;

Boell, Boris ;

von Tresckow, Bastian ;

Diehl, Volker ;

Hallek, Michael ;

Borchmann, Peter ;

Stein, Harald ;

Eich, Hans ;

Engert, Andreas .

LANCET, 2015, 385 (9976) :1418-1427

[3] Screening, Assessment, and Management of Fatigue in Adult Survivors of Cancer: An American Society of Clinical Oncology Clinical Practice Guideline Adaptation [J].

Bower, Julienne E. ;

Bak, Kate ;

Berger, Ann ;

Breitbart, William ;

Escalante, Carmelita P. ;

Ganz, Patricia A. ;

Schnipper, Hester Hill ;

Lacchetti, Christina ;

Ligibel, Jennifer A. ;

Lyman, Gary H. ;

Ogaily, Mohammed S. ;

Pirl, William F. ;

Jacobsen, Paul B. .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (17) :1840-U127

[4] Cytokine Genetic Variations and Fatigue Among Patients With Breast Cancer [J].

Bower, Julienne E. ;

Ganz, Patricia A. ;

Irwin, Michael R. ;

Castellon, Steven ;

Arevalo, Jesusa ;

Cole, Steven W. .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (13) :1656-+

[5] Randomized Controlled Trial of the Effects of Aerobic Exercise on Physical Functioning and Quality of Life in Lymphoma Patients [J].

Courneya, Kerry S. ;

Sellar, Christopher M. ;

Stevinson, Clare ;

McNeely, Margaret L. ;

Peddle, Carolyn J. ;

Friedenreich, Christine M. ;

Tankel, Keith ;

Basi, Sanraj ;

Chua, Neil ;

Mazurek, Alex ;

Reiman, Tony .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (27) :4605-4612

[6] Chronic fatigue in Hodgkin lymphoma survivors and associations with anxiety, depression and comorbidity [J].

Daniels, L. A. ;

Oerlemans, S. ;

Krol, A. D. G. ;

Creutzberg, C. L. ;

van de Poll-Franse, L. V. .

BRITISH JOURNAL OF CANCER, 2014, 110 (04) :868-874

[7] Persisting fatigue in Hodgkin lymphoma survivors: a systematic review [J].

Daniels, Laurien A. ;

Oerlemans, Simone ;

Krol, Augustinus D. G. ;

van de Poll-Franse, Lonneke V. ;

Creutzberg, Carien L. .

ANNALS OF HEMATOLOGY, 2013, 92 (08) :1023-1032

[8] Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial [J].

Engert, Andreas ;

Haverkamp, Heinz ;

Kobe, Carsten ;

Markova, Jana ;

Renner, Christoph ;

Ho, Antony ;

Zijlstra, Josee ;

Kral, Zdenek ;

Fuchs, Michael ;

Hallek, Michael ;

Kanz, Lothar ;

Doehner, Hartmut ;

Doerken, Bernd ;

Engel, Nicole ;

Topp, Max ;

Klutmann, Susanne ;

Amthauer, Holger ;

Bockisch, Andreas ;

Kluge, Regine ;

Kratochwil, Clemens ;

Schober, Otmar ;

Greil, Richard ;

Andreesen, Reinhard ;

Kneba, Michael ;

Pfreundschuh, Michael ;

Stein, Harald ;

Eich, Hans Theodor ;

Mueller, Rolf-Peter ;

Dietlein, Markus ;

Borchmann, Peter ;

Diehl, Volker .

LANCET, 2012, 379 (9828) :1791-1799

[9] Quality of life assessment in Hodgkin's disease:: A new comprehensive approach -: First experiences from the EORTC/GELA and GHSG trials [J].

Flechtner, H ;

Rüffer, JU ;

Henry-Amar, M ;

Mellink, WAM ;

Sieber, M ;

Fermé, C ;

Eghbali, H ;

Josting, A ;

Diehl, V .

ANNALS OF ONCOLOGY, 1998, 9 :147-154

[10] PSYCHOSOCIAL PROBLEMS AMONG SURVIVORS OF HODGKINS-DISEASE [J].

FOBAIR, P ;

HOPPE, RT ;

BLOOM, J ;

COX, R ;

VARGHESE, A ;

SPIEGEL, D .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (05) :805-814

← 1 2 3 4 →